Skip to main content
MyCapitol LogoMyCapitol

S 1930 · 119th Congress

Small Biotech Innovation Act

This bill creates an exception to Medicare's drug price negotiation program for small biotech companies that focus heavily on research and development. Starting in 2029, certain drugs made by these smaller companies won't be subject to the government's ability to negotiate lower prices. Here's who qualifies: A comp…

Sponsor
Cassidy, Bill (R-Louisiana)
Introduced
2025-06-03
Policy area
Health
Latest action
Read twice and referred to the Committee on Finance.

Digging through Congress... 🔍